Top Ten 2026: Drug Pricing & Reimbursement—Key Legal Challenges Ahead

• February 27, 2026

Based on AHLA's annual Health Law Connections article, this special ten-part series brings together thought leaders from across the health law field to discuss the top ten issues of 2026. In the sixth episode, Mary R. Kohler, Founder & Principal, Kohler Health Law PC, speaks with Kristie C. Gurley, Partner, Covington & Burling LLP, about the targeted reform and broad shifts that U.S. drug pricing is currently undergoing. They discuss issues related to Inflation Reduction Act implementation, litigation, the Trump Administration’s approach to drug pricing, pharmacy benefit managers, and 340B. From AHLA’s Life Sciences Practice Group.